2023-08-01 12:56:07 ET
- Editas Medicine ( NASDAQ: EDIT ) is scheduled to announce Q2 earnings results on Wednesday, August 2nd, before market open.
- The consensus EPS Estimate is -$0.77 (vs. -$0.78 last year) and the consensus Revenue Estimate is $4.39M (-31.0% Y/Y).
- Over the last 1 year, EDIT has beaten EPS estimates 75% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 8 upward revisions and 2 downward. Revenue estimates have seen 2 upward revisions and 1 downward.
For further details see:
Editas Medicine Q2 2023 Earnings Preview